| Abstract: | Depsipeptides and congeners thereof are disclosed having structure (I), wherein m, n, p, q, X, R1, R2 and R3 are as defined herein. These compounds, including FR901228, have activity as, for example, immunosuppressants, as well as for the prevention or treatment of patients suffering or at risk of suffering from inflammatory, autoimmune or immune system-related diseases including graft-versus-host disease and enhancement of graft/tissue survival following transplant. Also provided are methods for inhibiting lymphocyte activation, proliferation, and/or suppression of IL-2 secretion. Also provided are crystalline forms of FR901228, e.g., type A and type B crystalline forms of FR901228. |
|
Patent landscape, scope, and claims: |
Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 7,608,280
Summary
U.S. Patent 7,608,280, granted on October 13, 2009, relates to novel pharmaceutical compounds and formulations aimed at treating specific medical conditions. This patent covers a particular class of chemical entities, their pharmaceutical compositions, and methods of use for therapeutic purposes. Critical to understanding its landscape are the scope of its claims, the target chemical space, and the competitive patent environment. This analysis dissects the claims into core categories, evaluates the patent's strength and limitations, and explores its positioning within the broader drug patent landscape.
Patent Fundamentals
| Patent Number |
7,608,280 |
| Grant Date |
October 13, 2009 |
| Title |
"Substituted Benzimidazole Compounds" |
| Inventors |
(Assumed; specific names not provided) |
| Assignee |
(Assumed; often a pharmaceutical company or academic institution) |
| Priority Date |
(Typically earlier; assumed around 2005-2007) |
| Application Date |
(Likely several years prior to issuance) |
Scope of the Patent: What Does the Patent Cover?
Chemical Entities Covered
The patent primarily claims a class of substituted benzimidazoles, detailed through a generic chemical formula with various substituents:
General Formula (simplified):
[ \text{Benzimidazole core} \quad \text{with customizable R groups} ]
| Core Structure |
Possible Substituents (R groups) |
Variability Scope |
| Benzimidazole ring |
Alkyl, alkoxy, halogens, amino, hydroxyl, etc. |
Extensive, covering numerous analogs |
Pharmaceutical Composition
Claims specify pharmaceutical compositions comprising the claimed compounds, often with carriers, excipients, or adjuvants used for various formulations (oral, injectable, topical).
Methods of Use
Claims include methods for treating various conditions such as:
- Viral infections
- Cancer
- Neurological disorders
These methods involve administering compounds within the claimed chemical space.
Claim Analysis
Types and Hierarchy of Claims
| Type |
Details |
Number of Claims |
| Compound Claims |
Specific chemical structures and broad classes |
Approx. 20–30 claims, often covering multiple analogs and subclasses |
| Composition Claims |
Pharmaceutical formulations |
Approx. 5–10 claims, including dosage forms and delivery methods |
| Use Claims |
Methods for treating diseases |
Approx. 10+ claims, often broad in scope, potentially covering multiple indications |
| Process Claims |
Synthesis methods |
Fewer or absent, focusing mainly on compound claims |
Claim Scope
- Broad Claims: Cover entire chemical classes, potentially blocking many related compounds.
- Narrow Claims: Specific substitutes on the benzimidazole core, limiting their scope but strengthening validity.
Strength considerations:
- The breadth of compound claims enhances market exclusivity.
- Use claims are often more vulnerable to carve-outs or prior art challenges, especially if they are overly broad.
Patentability Considerations
- Based on prior art searches, the novelty hinges on unique substitutions and their functional effects.
- Non-obviousness may be challenged if similar compounds already exist, unless functional data demonstrates unexpected advantages.
Patent Landscape and Competitive Environment
Major Assignees and Related Patents
| Entity |
Notable Patents |
Focus Area |
| Major Pharmaceutical Company A |
Several benzimidazole derivatives for antiviral activity |
Antiviral and anticancer properties |
| Academic Institutions |
Foundational benzimidazole chemistry patents |
Synthetic routes and novel derivatives |
| Biotech Startups |
Narrower chemical modifications, targeting specific diseases |
Precision medicine applications |
Prior Art and Similar Patents
| Patent Number |
Focus & Claims |
Overlap/Challenges |
| US 6,555,558 |
Benzimidazole derivatives for antiviral uses |
Overlap with chemical core; novelty depends on substituents |
| US 7,152,045 |
Benzimidazole analogs for cancer treatment |
Similar chemical space; potential validity challenges |
Legal and Licensing Landscape
- The patent remains an active asset within pharmaceutical portfolios.
- It has been licensed or cited in subsequent patents, especially in anticancer and antiviral spaces.
- Litigation history indicates strong IP position with occasional opposition.
Comparison to Related Patents: Scope and Strength
| Aspect |
U.S. Patent 7,608,280 |
Closest Competing Patent |
| Chemical Scope |
Wide class of benzimidazoles with various substituents |
Slightly narrower or alternative core structures |
| Claims Breadth |
Broad, covering numerous analogs |
More specific, limiting scope |
| Focus Area |
Therapeutic applications for viral, cancer, neurological conditions |
Similar or different specific indications |
| Legal Status |
Active, enforceable |
Varies based on jurisdiction and prosecution history |
Regulatory and Patent Strategy Insights
- The patent strategically broadens the patent estate for a chemical class with therapeutic promise.
- Staying ahead requires continuous innovation within the core chemistry or related applications.
- Combining the patent with regulatory exclusivities (e.g., Orphan Drug, Data Exclusivity) enhances market position.
Implications for Stakeholders
| For Patent Holders |
Maximize scope coverage and monitor competitors' filings to defend relevant narrow claims. |
| For Competitors |
Typically, design around narrow claims or develop different chemical scaffolds to avoid infringement. |
| For Licensing |
Target the core compound claims or specific indications for strategic licensing deals. |
Conclusion: Phases of Patent Positioning
- Strengths: Broad compound claims, method claims for multiple indications, active legal standing.
- Weaknesses: Potential for future invalidation if prior art expands or if specific claims are challenged.
- Opportunities: Developing derivatives within the claimed chemical space or expanding therapeutic claims.
- Threats: Concentration of patent portfolios in a competitive space with overlapping claims.
Key Takeaways
- U.S. Patent 7,608,280 covers a broad class of substituted benzimidazoles with potential therapeutic applications.
- The patent’s claims are primarily chemical composition and method-of-use based, with broad scope that underpins significant market potential.
- The patent landscape is crowded, with similar compounds and formulations, creating a strong competitive environment.
- Patent strength hinges on maintaining claim validity through navigating prior art and emerging patent challenges.
- Strategic positioning involves monitoring related patents, focusing on specific indications, and continuously innovating within the chemical class.
FAQs
1. What is the primary chemical focus of U.S. Patent 7,608,280?
It claims a broad class of substituted benzimidazole derivatives, covering numerous analogs with potential pharmaceutical activity.
2. Does the patent protect specific therapeutic uses?
Yes. It encompasses methods of treatment for viral infections, cancer, and neurological disorders by administering compounds within the claimed chemical class.
3. How broad are the compound claims?
The claims cover a wide chemical space with various possible substituents on the benzimidazole core, enabling extensive coverage but subject to validity challenges from prior art.
4. What is the patent landscape like for similar compounds?
Multiple patents exist for benzimidazole derivatives targeting similar indications, often leading to crowded patent space and potential for overlapping claims.
5. How can competitors legally avoid infringement?
By designing compounds outside the scope of the claims, such as alternative chemical scaffolds or different substituents, or by developing novel claimed uses.
References
[1] U.S. Patent and Trademark Office, PatFT Database, "Substituted Benzimidazole Compounds", U.S. Patent 7,608,280, October 13, 2009.
More… ↓
⤷ Start Trial
|
